Beijing Strong Biotechnologies, Inc.

Shenzhen Stock Exchange 300406.SZ

Beijing Strong Biotechnologies, Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 13.85

Beijing Strong Biotechnologies, Inc. Price to Earnings Ratio (P/E) is 13.85 on January 14, 2025, a -34.21% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Beijing Strong Biotechnologies, Inc. 52-week high Price to Earnings Ratio (P/E) is 23.29 on March 04, 2024, which is 68.11% above the current Price to Earnings Ratio (P/E).
  • Beijing Strong Biotechnologies, Inc. 52-week low Price to Earnings Ratio (P/E) is 12.67 on September 23, 2024, which is -8.59% below the current Price to Earnings Ratio (P/E).
  • Beijing Strong Biotechnologies, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 17.18.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Shenzhen Stock Exchange: 300406.SZ

Beijing Strong Biotechnologies, Inc.

CEO Mr. Xi Liu
IPO Date Oct. 30, 2014
Location China
Headquarters Kuang Yi Building
Employees 1,094
Sector Health Care
Industries
Biotechnology Chemicals & Advanced Materials Pharmaceuticals
Description

Beijing Strong Biotechnologies, Inc. provides in-vitro diagnostics products and services in the People's Republic of China and internationally. It offers clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; and serology products comprising blood type test cards and automated blood grouping analyzers. The company was founded in 2001 and is headquartered in Beijing, the People's Republic of China.

StockViz Staff

January 15, 2025

Any question? Send us an email